More

    WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA



    [
    WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA
    [og_img]
    https://www.investing.com/news/press-releases/wuxi-biologics-congratulates-partner-canbridge-pharmaceuticals-on-the-approval-of-innovative-velaglucerasebeta-for-injection-gaurunning-for-gaucher-disease-by-china-nmpa-93CH-4051513


    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img